Merck Stock Slumps as Q4 Profits, 2025 Forecast Fall Short

Key TakeawaysMerck shares fell sharply Tuesday morning after the drugmaker's profits and 2025 outlook fell short of estimates.Revenue and adjusted earnings, however, managed to top expectations.Sales of a few Merck drugs were hit by lower international demand and lower pricing in the U.S., the company said. Merck shares tumbled Tuesday morning after the drugmaker's soft outlook outweighed fourth-quarter revenue that topped expectations. Merck (MRK) reported $15.62 billion in revenue for the quarter, up 7% y ...